Health Care Distributors

Henry Schein

Henry Schein Reports Strong Dental Growth and Commits to $125M Savings Target

Henri Shen Highlights Sales Growth and Earnings in Q1 Earnings Call

Henry Schein's Online Platform Dominates US Dental E-commerce Sales

Henry Schein released FY2026 Q1 earnings on May 5 Pre-Market EST, actual revenue USD 3.368 B (forecast USD 3.342 B), actual EPS USD 0.9199 (forecast USD 0.8509)

Henry Shane Announces Q1 Earnings Per Share of $0.92

Henry Schein to Release FY2026 Q1 Earnings on May 5 Pre-Market EST, Forecast Revenue USD 3.342 B, EPS USD 0.8509

Henry Schein CEO Stanley M. Bergman Sells Company Shares

Henny Shane Announces Q4 2025 Earnings Call Transcript

Morgan Stanley Raises Henry Schein's Target Price to $61

Henry Schein released FY2025 Q4 earnings on February 24 Pre-Market (EST), actual revenue USD 3.437 B (forecast USD 3.346 B), actual EPS USD 0.8499 (forecast USD 1.0183)

Henry Schein released FY2025 earnings on February 24 Pre-Market (EST), actual revenue USD 13.18 B (forecast USD 13.08 B), actual EPS USD 3.27 (forecast USD 3.3943)

Hennixian Fourth Quarter Earnings Per Share of $0.85 Announced

Henry Schein Collaborates with Align Technology to Integrate iTero™ Scanner

Henry Schein to Release FY2025 Q4 Earnings on February 24, 2026, Pre-Market EST; Forecast Revenue USD 3.343 B, EPS USD 1.0171

Forecast for the Next Earnings Report of Henry Shann

Henryschein Expands Agreement with vVARDIS and Secures Exclusive US Distribution Rights for Curodont Repair

Henry Schein Unveils First AI and Automation Workflow at Dental Conference

UBS Analyst Maintains Hold Rating on Henry Schein

Morgan Stanley Maintains Sell Rating on Henry Schein

Henry Schein and VideaHealth Collaborate to Launch Impact Panel

Agape ATP

Akanda

Co-Diagnostics

Netcapital

Tradr 2X Long QBTS Daily ETF

Tradr 2X Long RGTI Daily ETF

Defiance Daily Target 2X Long RGTI ETF

PicoCELA

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NewGenIvf

HSIC

Henry Schein Stock: Is Wall Street Bullish or Bearish?

Barchart Option

Henry Schein Stock: Is Wall Street Bullish or Bearish?

Sensei has launched Sensei Cloud Apps, a new cloud-based platform for dental practices that enhances daily planning, patient communication, and operational efficiency without replacing existing management systems. The platform integrates tools like Morning Huddle, Cloud Scheduler, and Team Chat, providing a centralized view and real-time support. It aims to improve practice connectivity and flexibility, allowing teams to prepare effectively and respond quickly. Early access is available for Sensei customers, with a full rollout planned soon.

Fidelity

Sensei Launches Sensei Cloud Apps to Bring Cloud Capabilities to Every Dental Practice

Henry Schein (NASDAQ:HSIC) reports strong momentum in its dental business, with a commitment to a $125 million savings goal despite softness in the medical sector due to a weaker respiratory illness season. CEO Fred Lowery highlighted growth in technology and distribution, while CFO Ron South noted that operational savings will be more pronounced in the second half of the year. The company aims to enhance customer value through AI and commercial alignment, while also focusing on gross profit optimization and maintaining competitive pricing.

Market Beat

Bank of America

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

Henry Schein Highlights Dental Momentum, $125M Savings Goal Despite Medical Softness

Shares of Henry Schein Inc. (HSIC) rose 4.55% to $72.61 on a strong trading day, outperforming competitors like Stryker Corp. and IDEXX Laboratories. This marks the third consecutive day of gains for the stock, which remains 18.68% below its 52-week high of $89.29. The S&P 500 and Dow Jones also saw increases of 0.77% and 0.75%, respectively, with trading volume significantly above average at 3.1 million shares.

MarketWatch Automated

S&P 500

Dow Jones Industrial Average

Stryker

IDEXX Labs

McKesson

Henry Schein Inc. Stock Outperforms Competitors On Strong Trading Day

SBIO

Agilent Technologies Inc. shares fell 3.60% to $111.46 on Monday, marking the second consecutive day of losses. The stock is now 30.45% below its 52-week high of $160.27. In contrast, the S&P 500 and Dow Jones both rose 0.19%. Competitors like Thermo Fisher, Danaher, and Abbott also experienced declines, but Agilent's performance was notably weaker. Trading volume matched its 50-day average at 2.2 million shares.

Agilent Tech

SPDR S&P Health Equip

iShares US Medical Devices

ALPS Medical Breakthrough

Thermo Fisher Scentific

Danaher

Abbott Laboratories

Agilent Technologies Inc. Stock Underperforms Monday When Compared To Competitors

Henry Schein Inc. (HSIC) shares fell 2.68% to $70.50 on Thursday, marking its second consecutive day of losses. The stock is currently 21.04% below its 52-week high of $89.29. In comparison, competitors Stryker Corp. rose 0.65%, while IDEXX Laboratories and McKesson Corp. saw declines and gains, respectively. The overall market also declined, with the S&P 500 down 0.38% and the Dow Jones down 0.63%. Trading volume for Henry Schein was 2.9 million, surpassing its 50-day average of 1.3 million.

Henry Schein Inc. Stock Underperforms Thursday When Compared To Competitors

Henry Schein (HSIC) reported Q1 2026 earnings that exceeded analyst expectations and reaffirmed its 2026 guidance. Despite a 3.23% decline in share price over the past 30 days, the company shows a positive long-term outlook with an 8.82% total shareholder return over the past year. The fair value is estimated at $90.21, indicating the stock is undervalued at its last close of $72.44. Key growth areas include high-margin businesses and investments in digital solutions, although risks such as competitive pricing and execution issues could impact margins.

Simplywall

A Look At Henry Schein’s Valuation As Q1 2026 Earnings Beat And Guidance Are Reaffirmed

As of Q1, more than 80% of U.S. dental ecommerce sales now go through HenrySchein.com, the medical supply company’s new consolidated online ordering platform.

digitalcommerce360

Henry Schein hits ecommerce platform goal in Q1

Henry Schein Inc. (HSIC) shares fell 2.60% to $72.44 on Wednesday, underperforming in a generally positive market where the S&P 500 rose 1.46%. The stock is currently 18.87% below its 52-week high of $89.29. In comparison, competitors had mixed results: Stryker Corp. (SYK) decreased by 0.99%, IDEXX Laboratories Inc. (IDXX) increased by 2.89%, and McKesson Corp. (MCK) dropped by 7.16%.

Factset Research

Henry Schein Inc. Stock Underperforms Wednesday When Compared To Competitors

Stifel Nicolaus analyst Jonathan Block has reiterated a Hold rating on Henry Schein (HSIC) with a price target of $84.00. Block, who focuses on the Healthcare sector, has an average return of 4.1% and a 46.95% success rate on his stock recommendations. Additionally, BTIG's David Larsen also issued a Hold rating on Henry Schein, while Barclays maintained a Buy rating on the stock.

Henry Schein(HSIC.US)

Henry Schein Stock: Is Wall Street Bullish or Bearish?

Sensei Launches Sensei Cloud Apps to Bring Cloud Capabilities to Every Dental Practice

Henry Schein Highlights Dental Momentum, $125M Savings Goal Despite Medical Softness

Henry Schein Inc. Stock Outperforms Competitors On Strong Trading Day

Agilent Technologies Inc. Stock Underperforms Monday When Compared To Competitors

Henry Schein Inc. Stock Underperforms Thursday When Compared To Competitors

A Look At Henry Schein’s Valuation As Q1 2026 Earnings Beat And Guidance Are Reaffirmed

Henry Schein hits ecommerce platform goal in Q1

Henry Schein Inc. Stock Underperforms Wednesday When Compared To Competitors

Stifel Nicolaus Keeps Their Hold Rating on Henry Schein (HSIC)